0.3600
-0.0040
(-1.10%)
At close: April 17 at 8:08:24 AM GMT+2
Key Executives
Key Executives Information Not Available
Lineage Cell Therapeutics Inc
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Lineage Cell Therapeutics Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 7, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC
Lineage Cell Therapeutics Inc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
DBV.F DBV Technologies S.A.
1.2520
+1.79%
05Y.MU Vivoryon Therapeutics NV
1.7140
0.00%
MVR0.BE Medivir AB
0.1372
-2.42%
ICY.HA Incyte Corp
51.16
-0.31%
PROT Proteonomix, Inc.
0.0000
0.00%
0M4.DU Mersana Therapeutics Inc
0.3157
+12.99%
HTD.MU Corcept Therapeutics Inc
57.90
-3.60%
MVR0.F Medivir AB (publ)
0.1458
-1.88%
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
96X.F FluoGuide A/S
3.1700
0.00%